An mHealth Strategy to Improve Medication Adherence in Adolescents With Sickle Cell Disease
Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The primary objective of this study is to evaluate a potential behavioral intervention (MED-Go app). To meet this objective, the researchers will conduct a pilot randomized controlled trial to test the feasibility and acceptability of MED-Go app in adolescents and young adults (AYA) with sickle cell disease (SCD). The long-term goal of this research is to promote medication adherence behavior and improve health outcomes in AYA with SCD.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 12
Maximum Age: 21
Healthy Volunteers: f
View:
• Age 12-21 years old
• Any sickle cell disease genotype
• On steady state of hydroxyurea for 2 months
• Own of have access to a smartphone during the study period
Locations
United States
Illinois
Ann & Robert H Lurie Children's Hospital of Chicago
RECRUITING
Chicago
Contact Information
Primary
Sherif M Badawy, MD, MS
sbadawy@luriechildrens.org
(312) 227-4836
Backup
Savannah Winkler, BS
swinkler@luriechildrens.org
(312) 227-4807
Time Frame
Start Date: 2020-09-28
Estimated Completion Date: 2025-02-01
Participants
Target number of participants: 40
Treatments
Other: MED-Go app Intervention
Participants will use MED-Go app intervention for a total of 12 weeks
No_intervention: Control Arm
Standard of care
Related Therapeutic Areas
Sponsors
Leads: Ann & Robert H Lurie Children's Hospital of Chicago
Collaborators: National Heart, Lung, and Blood Institute (NHLBI)